ALMAJECT

Trademark usage description

injectable pharmaceuticals for treatment of fungal infections, metastatic tumors, cancers, side effects caused by chemotherapy, moderate to severe pai Read More

Classification Information

Class [005]
Injectable pharmaceuticals for treatment of fungal infections, metastatic tumors, cancers, side effects caused by chemotherapy, moderate to severe pain, hypertension, bacterial infections being cholera, diphtheria, dysentery, tuberculosis, typhoid, typhus, bacterial meningitis, pink eye, urinary tract infections, skin infections and sexually transmitted infections (STIs), and bleeding cessation being blood clotting factors, antifibrinolytic agents, and platelets; pharmaceutical preparations, namely, injectable antineoplastic agents for the treatment of cancer, iron chelating agents for the treatment of iron overload, sedatives, and muscle relaxants

Classification kind code

Mark Details

Serial Number

2031513

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 190 on 8^th Nov 2024	Registration Pending
Submitted for opposition 55 on 8^th Nov 2024	Registered
Submitted for opposition 42 on 21^st Aug 2024	Advertised
Submitted for opposition 27 on 23^rd Jul 2024	Approval Notice Sent
Submitted for opposition 26 on 23^rd Jul 2024	Approved
Submitted for opposition 22 on 15^th Jul 2024	Search Recorded
Submitted for opposition 287 on 9^th Jun 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 1^st Jun 2020	Filed
Submitted for opposition 1 on 1^st Jun 2020	Created
Submitted for opposition 31 on 1^st Jun 2020	Formalized